» Articles » PMID: 35506039

Research Highlights on Contributions of Mitochondrial DNA Microsatellite Instability in Solid Cancers - an Overview

Overview
Publisher Termedia
Specialty Oncology
Date 2022 May 4
PMID 35506039
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer has been broadly considered a genetic disease involving mutations in nuclear DNA and the mitochondrial genome (mtDNA). Mitochondria are essential bioenergetics and biosynthetic machinery found in most eukaryotic organisms. Thus, failure of their function is crucial for tumourigenesis, tumour cell growth, and metastasis. Mitochondrial dysregulation can occur as a consequence of molecular alterations in mtDNA, such as point mutations, deletions, inversions, microsatellite instability (MSI), and copy number variations. This review article aims to highlight the published research work on alterations in mtDNA, with a particular focus on mitochondrial MSI (mtMSI) in various types of solid cancers. Databases including PubMed, Scopus, and Google Scholar were searched for articles about mtMSI and its link to solid cancer published from 1990 till 2021. In this review, we briefly summarize the knowledge related to possible molecular mechanisms causing mtMSI formation and the available information on mtMSI frequency values in all main solid cancer types. Mutations in the mitochondrial genome are widely believed to have a broad impact across various cancers. Based on the available published data, mtMSI can act as a vital risk factor and a potential marker for cancer progression. Further research is required to unravel the role of mtMSI in tumourigenesis.

Citing Articles

The effect of somatic mutations in mitochondrial DNA on the survival of patients with primary brain tumors.

Mohd Khair S, Ab Radzak S, Idris Z, Mat Zin A, Wan Ahmad W, Yusoff A Croat Med J. 2024; 65(2):111-121.

PMID: 38706237 PMC: 11074945.


Mitochondrial Deoxyribonucleic Acid (mtDNA), Maternal Inheritance, and Their Role in the Development of Cancers: A Scoping Review.

Vadakedath S, Kandi V, Ca J, Vijayan S, Achyut K, Uppuluri S Cureus. 2023; 15(6):e39812.

PMID: 37397663 PMC: 10314188. DOI: 10.7759/cureus.39812.


Mapping mitonuclear epistasis using a novel recombinant yeast population.

Nguyen T, Tinz-Burdick A, Lenhardt M, Geertz M, Ramirez F, Schwartz M PLoS Genet. 2023; 19(3):e1010401.

PMID: 36989278 PMC: 10085025. DOI: 10.1371/journal.pgen.1010401.


Mitochondrial Control Region Variants Related to Breast Cancer.

Vega Avalos J, Hernandez L, Zuniga L, Sanchez-Parada M, Gonzalez Santiago A, Roman Pintos L Genes (Basel). 2022; 13(11).

PMID: 36360199 PMC: 9690046. DOI: 10.3390/genes13111962.


Insights regarding mitochondrial DNA copy number alterations in human cancer (Review).

Abd Radzak S, Mohd Khair S, Ahmad F, Patar A, Idris Z, Yusoff A Int J Mol Med. 2022; 50(2).

PMID: 35713211 PMC: 9304817. DOI: 10.3892/ijmm.2022.5160.

References
1.
Huang Y, Li G . DNA mismatch repair in the context of chromatin. Cell Biosci. 2020; 10:10. PMC: 6996186. DOI: 10.1186/s13578-020-0379-7. View

2.
Chang S, Lin P, Yang S, Wang H, Liang W, Lin J . Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis. 2009; 24(6):623-8. DOI: 10.1007/s00384-009-0663-9. View

3.
Mohd Khair S, Abd Radzak S, Yusoff A . The Uprising of Mitochondrial DNA Biomarker in Cancer. Dis Markers. 2021; 2021:7675269. PMC: 8302403. DOI: 10.1155/2021/7675269. View

4.
Kumar B, Bhat Z, Bansal S, Saini S, Naseem A, Wahabi K . Association of mitochondrial copy number variation and T16189C polymorphism with colorectal cancer in North Indian population. Tumour Biol. 2017; 39(11):1010428317740296. DOI: 10.1177/1010428317740296. View

5.
Hendriks Y, de Jong A, Morreau H, Tops C, Vasen H, Wijnen J . Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin. 2006; 56(4):213-25. DOI: 10.3322/canjclin.56.4.213. View